» Articles » PMID: 8608944

Differential Activation of Adipogenesis by Multiple PPAR Isoforms

Overview
Journal Genes Dev
Specialty Molecular Biology
Date 1996 Apr 15
PMID 8608944
Citations 111
Authors
Affiliations
Soon will be listed here.
Abstract

Peroxisome proliferator-activated receptor gamma (PPARgamma) is a nuclear hormone receptor expressed predominantly in adipose tissue, where it plays a central role in the control of adipocyte gene expression and differentiation. Because there are two additional PPAR isoforms, PPARalpha and PPARdelta, and these are also expressed at some level in certain adipose depots, we have compared directly the adipogenic potential of all three receptors. Ectopically expressed PPARgamma powerfully induces adipogenesis at a morphological and molecular level in response to a number of PPARgamma activators. PPARalpha is less adipogenic but is able to induce significant differentiation in response to strong PPARalpha activators. Expression and activation of PPARdelta did not stimulate adipogenesis. Of the three PPARs, only PPARgamma can cooperate with C/EBPalpha in the promotion of adipogenesis. To begin to investigate the functional basis for the differential adipogenic activity of the PPAR isoforms, we have examined their ability to bind to several PPAR DNA response sequences. Compared with PPARalpha and PPARdelta, PPARgamma shows preferential binding to two well-characterized regulatory sequences derived from a fat-specific gene, ARE6 and ARE7. These data strongly suggest that PPARgamma is the predominant receptor regulating adipogenesis; however, they also suggest that PPARalpha may play a role in differentiation of certain adipose depots in response to a different set of physiologic activators or in certain disease states.

Citing Articles

Evaluation of the protective effect of Curcuma longa and PPARγ agonist, pioglitazone on paraquat-induced lung injury in rats.

Eshaghi Ghalibaf M, Taghavi Zadeh Yazdi M, Mansourian M, Mohammadian Roshan N, Boskabady M Immun Inflamm Dis. 2024; 12(8):e70001.

PMID: 39172009 PMC: 11340013. DOI: 10.1002/iid3.70001.


PPARs in Clinical Experimental Medicine after 35 Years of Worldwide Scientific Investigations and Medical Experiments.

Skoczynska A, Oldakowska M, Dobosz A, Adamiec R, Gritskevich S, Jonkisz A Biomolecules. 2024; 14(7).

PMID: 39062500 PMC: 11275227. DOI: 10.3390/biom14070786.


Potential Antidiabetic Activity of β-sitosterol from Modulation of Peroxisome Proliferator-activated Receptor Gamma (PPARγ).

Amanat M, Ud Daula A, Singh R Comb Chem High Throughput Screen. 2024; 27(11):1676-1699.

PMID: 38305397 DOI: 10.2174/0113862073260323231120134826.


The fat accumulation promotion effects of dihydrxytetraphenylmethane and its underlying mechanisms via transcriptome analysis.

Wang G, Huang Y, Gao Y, Chen G, Cui L, Peng Y Curr Res Food Sci. 2023; 7:100534.

PMID: 37441166 PMC: 10333433. DOI: 10.1016/j.crfs.2023.100534.


Role of SUMO-Specific Protease 2 in Leptin-Induced Fatty Acid Metabolism in White Adipocytes.

Kim P, Lee J, Chung S, Park K Diabetes Metab J. 2023; 47(3):382-393.

PMID: 36872063 PMC: 10244199. DOI: 10.4093/dmj.2022.0156.